SARS-CoV-2 Transmission in Patients With Cancer at a Hospital in China

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 25, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.0980?guestAccessKey=958b15ee-5658-4cbf-9d3d-f7a1639c4f5a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032520

 

What The Study Did: Researchers estimated the infection rate of SARS-CoV-2 in patients with cancer and reported on patient outcomes at a single hospital in Wuhan, China.

Authors: Conghua Xie, M.D., of Zhongnan Hospital of Wuhan University in China, and Melvin L. K. Chua, M.B.B.S., Ph.D., of the National Cancer Centre Singapore, are the corresponding authors.   

(doi:10.1001/jamaoncol.2020.0980)

Editor’s Note: The article includes funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

 

estimated the infection rate of SARS-CoV-2 in pa- tients with cancer and report on patient outcomes from a single hospital in Wuhan, China.